Search

Your search keyword '"MacKenzie AE"' showing total 146 results

Search Constraints

Start Over You searched for: Author "MacKenzie AE" Remove constraint Author: "MacKenzie AE"
146 results on '"MacKenzie AE"'

Search Results

2. The context, measures and outcomes of psychosocial care interventions in long-term health care for older people.

4. Coping with a child with Down syndrome: the experiences of mothers in Hong Kong.

5. Psychosocial consequences of falling: the perspective of older Hong Kong Chinese who had experienced recent falls.

6. A review of older people's experiences with residential care placement.

8. Needs of families with a relative in a critical care unit in Hong Kong.

9. Chinese elderly patients' perceptions of their rehabilitation needs following a stroke.

11. Case management: a review of the definitions and practices.

12. A review of the historical and social processes contributing to care and caregiving in Chinese families.

13. Evaluating ethnography: considerations for analysis.

14. Learning from experience in the community: an ethnographic study of district nurse students.

18. Sewer transport conditions and their role in the decay of endogenous SARS-CoV-2 and pepper mild mottle virus from source to collection.

19. Corrigendum: Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, Canada.

20. Impact of coagulation on SARS-CoV-2 and PMMoV viral signal in wastewater solids.

21. Wastewater-based surveillance identifies start to the pediatric respiratory syncytial virus season in two cities in Ontario, Canada.

22. Rapidly developed, optimized, and applied wastewater surveillance system for real-time monitoring of low-incidence, high-impact MPOX outbreak.

23. Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.

24. Understanding the dynamic relation between wastewater SARS-CoV-2 signal and clinical metrics throughout the pandemic.

25. Wastewater to clinical case (WC) ratio of COVID-19 identifies insufficient clinical testing, onset of new variants of concern and population immunity in urban communities.

26. Physical Activity, Gut Microbiota, and Genetic Background for Children and Adolescents with Autism Spectrum Disorder.

27. Municipal and neighbourhood level wastewater surveillance and subtyping of an influenza virus outbreak.

28. Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy.

29. Quantitation of phosphatidylethanols in dried blood spots to determine rates of prenatal alcohol exposure in Ontario.

30. COVID-19 wastewater surveillance in rural communities: Comparison of lagoon and pumping station samples.

31. G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in Hepatocytes.

32. Anatomy and White Matter Connections of the Superior Parietal Lobule.

33. Catching a resurgence: Increase in SARS-CoV-2 viral RNA identified in wastewater 48 h before COVID-19 clinical tests and 96 h before hospitalizations.

34. G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis.

35. Anatomy and White Matter Connections of the Parahippocampal Gyrus.

36. Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence.

38. Combinatorial expression of GPCR isoforms affects signalling and drug responses.

39. Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.

40. Receptor selectivity between the G proteins Gα 12 and Gα 13 is defined by a single leucine-to-isoleucine variation.

41. Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35.

42. The emerging pharmacology and function of GPR35 in the nervous system.

43. Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands.

44. Current and emerging treatment options for spinal muscular atrophy.

45. G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease.

46. G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation.

47. The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.

48. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism.

49. Rare-disease genetics in the era of next-generation sequencing: discovery to translation.

50. Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor.

Catalog

Books, media, physical & digital resources